Last update 08 Nov 2025

TQB3002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TQB3002
Target
EGFR
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Advanced cancerNeoplasms
Inactive Indication-
Originator Organization
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Active Organization
Sino Biopharmaceutical Ltd.Sino Biopharmaceutical Ltd.Chia Tai Tianqing PharmaceuticalChia Tai Tianqing PharmaceuticalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TQB3002
NCT06662760
/ RecruitingPhase 1
A Phase I Clinical Study of TQB3002 in Patients With Advanced Cancers
100 Clinical Results associated with TQB3002
Login to view more data
100 Translational Medicine associated with TQB3002
Login to view more data
100 Patents (Medical) associated with TQB3002
Login to view more data
100 Deals associated with TQB3002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
03 Dec 2024
NeoplasmsPreclinical
China
Chia Tai Tianqing PharmaceuticalChia Tai Tianqing Pharmaceutical
29 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT06662760 (TQB3002, AACR2025)
Phase 1
EGFR mutation-positive
-
imxoadqvhk(uqootixoyx) = tkwlpjzvhz wvzonlihfv (pkefckuwdt )
Positive
29 Apr 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free